Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma

被引：3
|
作者：
Kuo, Alyce M. [1 ]
Hassoun, Hani [2 ]
Shah, Urvi [2 ]
Gordon, Allison [1 ]
Hollmann, Travis J. [3 ]
Landau, Heather J. [4 ]
Lezcano, Cecilia [3 ]
Mailankody, Sham [2 ]
Tan, Carlyn C. [2 ]
Lesokhin, Alexander M. [2 ]
Markova, Alina [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, 545 E 73rd St, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, Dermatopathol Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
来源：
LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 09期
关键词：
CELLS; SKIN;
D O I：
10.1080/10428194.2022.2068002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2233 / 2237
页数：5
相关论文
共 50 条
  • [41] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    Dimopoulos, M. A.
    Swern, A. S.
    Li, J. S.
    Hussein, M.
    Weiss, L.
    Nagarwala, Y.
    Baz, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e257 - e257
  • [42] TREATMENT OF MULTIPLE RELAPSED/REFRACTORY MYELOMA WITH LENALIDOMIDE DEXAMETHASONE RETROSPECTIVE ANALYSIS OF 65 PATIENTS TREATED AT A CENTER
    Moya Arnao, M.
    Cabanas Perianes, V
    Moreno Balmonte, M. J.
    Martinez Marin, A.
    Fernandez Poveda, E.
    Navarro Almenzar, B.
    Berenguer Piqueras, M.
    Salido Fierez, E.
    Labbadia, F.
    Perez Lopez, R.
    Garcia Hernandez, A. M.
    Cerezo Manchado, J. J.
    Blanquer Blanquer, M.
    Martinez Garcia, A. B.
    Melero Amor, A.
    Garcia Candel, F.
    Moraleda Jimenez, J. M.
    HAEMATOLOGICA, 2017, 102 : 97 - +
  • [43] Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma
    Shamriz, Oded
    Parnasa, Elchanan
    Rubin, Limor
    Talmon, Aviv
    Ribak, Yaarit
    Lebel, Eyal
    Vainstein, Vladimir
    Aumann, Shlomzion
    Saban, Revital
    Gatt, Moshe E.
    Tal, Yuval
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (04) : 407 - 413
  • [44] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
    Paludo, Jonas
    Mikhael, Joseph R.
    LaPlant, Betsy R.
    Halvorson, Alese E.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen J.
    Dingli, David
    Go, Ronald S.
    Lin, Yi
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Stewart, A. Keith
    Reeder, Craig B.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    BLOOD, 2017, 130 (10) : 1198 - 1204
  • [45] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
  • [46] Lenalidomide is active for extramedullary disease in refractory multiple myeloma
    Nakazato, Tomonori
    Mihara, Ai
    Ito, Chisako
    Sanada, Yukinari
    Aisa, Yoshinobu
    ANNALS OF HEMATOLOGY, 2012, 91 (03) : 473 - 474
  • [47] Survival of Patients with Multiple Myeloma That Is Refractory to Both Bortezomib and Lenalidomide: A Retrospective Study
    Miyazaki, Kanji
    Suzuki, Kenshi
    BLOOD, 2018, 132
  • [48] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [49] Erratum: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e202 - e202
  • [50] Erratum: Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2008, 5 : 493 - 493
12345